Cancer Biomarkers Market Growth Drivers Insights:
According to the research study published by the DataM Intelligence, the global Cancer Biomarkers Market size is projected to reach USD billion by the end of 2029, with growth at a CAGR of approximately 13.2% during the forecast period 2022-2029.
Cancer biomarkers are biological molecules secreted either by tumors or from tissues in response to cancer, which are then later used to measure and evaluate the cancer growth processes in the body. Cancer biomarkers are used on or for the patients when undergoing curative cancer treatment; these can be further used to follow up the disease condition at the early stage or for the possible recurrent disease.
The global cancer biomarkers market growth is driven by the increasing use of cancer biomarkers in drug discovery and development, increasing research on cancer biomarkers, technological advancements, and the increasing global incidence of cancer.
To know more insights on Market Size, Demand, and Company Profile Analysis, Kindly Download Our Sample Brochure @ https://www.datamintelligence.com/download-sample/cancer-biomarkers-market
The presence of potential pipeline candidates is driving the market growth
Many pharmaceutical companies are actively investing in the research and development of novel biomarkers for the diagnosis and treatment of cancer. Many potential candidates are in their end stages of development and are projected to give a tremendous boost to the market after their launch.
This is limiting the number of patients undergoing biomarker testing, and the growing preference of patients toward other low-cost detection tests.
Report Statistics:
Metric
Details
Market CAGR
~13.2%
Fastest Growing Region
Asia Pacific
Largest Market
North America
Cancer Biomarkers Market Segmentation:
By Cancer Indication:
Sarcoma
Colorectal Cancer
Cervical Cancer
Lung Cancer
Breast Cancer
By Biomarker Type:
Protein Biomarkers
Genetic Biomarkers
Others
By Profiling Technology:
Omics Technologies
Cytogenetics
Immunoassays
Imaging Technologies
Bioinformatics
By Application:
Drug Discovery and Development
Disease Screening and Diagnosis
Treatment Planning & Risk Assessment
HER-2 segment held the largest share in 2021 due to the rising prevalence of breast cancer and increasing awareness about disease diagnosis in both developed and developing countries.
Geographical Classification:
Latin America
Europe
Middle East and Africa
Rest of the world
Cancer Biomarkers Market Regional Insights:
North America accounted for the largest share of the global cancer biomarkers market. The North American cancer biomarkers market’s growth can be attributed to the increasing R&D on cancer biomarkers and rising technological advancements in the development of cancer biomarkers. Moreover, the high incidence rate of cancer in the region propels market growth.
Make an Inquire before purchasing the full report @ https://www.datamintelligence.com/enquiry/cancer-biomarkers-market
Major Companies Profiled in the global Cancer Biomarkers Market:
Some of the key players which are contributing to the growth of the market include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., QIAGEN N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Merck Millipore, Agilent Technologies among others.
The Full Report has the below insights.
Additional Benefits Post Purchase:
Media ContactCompany Name: DataM IntelligenceContact Person: SaiEmail: Send EmailPhone: +1 877 441 4866Country: United StatesWebsite: https://www.datamintelligence.com/research-report/cancer-biomarkers-market